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Abstract
Introduction This study established two-dimensional gel
electrophoresis (2-DE) profiles for human well-differentiated
laryngeal squamous cell carcinoma tissue and paired normal
mucosa epithelia tissue and identified proteins with different
expressions. Well-resolved and reproducible 2-DE patterns of
well-differentiated laryngeal squamous cell carcinoma and
adjacent normal mucosa were obtained.
Results Thirteen proteins were preliminarily identified,
among which ten proteins including cofilin-1, nuclear body
protein SP140, GRP94, HSP 90, GSTP1-1, superoxide
dismutase [Mn], cyclophilin A, proteasome activator
complex subunit 2, apolipoprotein A-I precursor, and
CaM-like protein were upregulated and three proteins
including fatty acid-binding protein (E-FABP), calgranulin
A, and calgranulin B were downregulated in laryngeal
cancer tissue. The different expressions of cyclophilin A
and MRP8 were confirmed by Western blotting.
Discussion We first identified 13 proteins that might be
associated with the tumorigenesis of the laryngeal squa-
mous cell carcinoma. Some proteins were the products of
oncogenes and apoptosis and others were related to signal
transduction and immune defense. These extensive protein
variations indicated that multiple protein molecules were
simultaneously involved in the oncogenesis of laryngeal
cancer, which in turn is a basis for the rational designs of
diagnostic and therapeutic methods.
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Introduction
Laryngeal cancers represent a major health problem
worldwide, and laryngeal squamous cell carcinoma (LSCC)
is the most common type of laryngeal cancer. It is the one
not showing an increase in the 5-year survival rates over the
last 30 years. The increasing use of chemo- and radiother-
apy and conservative surgery to preserve organs and their
functions has probably led to a better quality of life in
patients with laryngeal cancer, but has definitely failed to
improve survival, which remains the primary aim. This
highlights the necessity for continued efforts to discover
suitable biomarkers for early diagnosis of the disease and to
understand its pathogenesis as a first step in improving
methods of treatment. Proteomics provides an effective
approach to study disease pathogenesis by globally exam-
ining the different protein expressions because of malignant
cell transformation in disease [1, 2].We have recently
identified tumor-associated proteins in LSCC by means of
proteomic technology. These tumor-associated proteins can
be further evaluated as potential biomarkers for clinical
diagnosis and as targeted proteins for pathogenetic inves-
tigations. The present findings may shed light on the
molecular characterization of laryngeal cancer progression
and may be informative for identifying biomarkers and
therapeutic targets for LSCC.
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Tissues used in this experiment were obtained with the
approval of the Committees for Ethical Review of Research
involving Human Subjects at Chongqing Medical Univer-
sity. A total of eight human LSCC tissues from patients
were collected immediately after isolation of surgically
resected in the First Affiliated Hospital of Chong Qing
Medical University, The eight cases included eight men
with an average age of 57 years. Tissue samples were
snapfrozen in liquid nitrogen and then preserved in −80°C
deep freezer or on dry ice for transfer before experiments.
The histology for all the eight samples was confirmed by
two independent histopathologist after fixation, embedding,
sectioning, and hematoxylin-and-eosin staining. All sam-
ples comprised more than 80% of the targeted cells (normal
epithelial cells or cancer cells) without necrosis. The
American Joint Committee on Cancer pathologic stages
were T2–4N0M0.
Preparation of Tissue Protein Samples
Fresh frozen laryngeal tissue samples (100–200 mg) were
cut into small pieces, dissolved in lysis buffer at the ratio of
80-mg tissue per 1,000-μl lysis buffer (8 mol/l urea, 2 mol/
l sulfourea,4% amphion detergent, 65 mmol/l dithiothreitol,
0.2% ampholite, 10 ml/l protease inhibitor cocktail), and
then homogenized for 5 min on ice with a minihomogen-
izer. The mixture was centrifuged at 4°C for 15 min to
remove tissue and cell debris. The supernatant was taken as
extracted proteins, and the protein concentration was
determined by the bicinchoninic acid method. Aliquots of
protein samples were kept in −80°C deep-freezer until
further use.
2-DE,Coomassie Staining, and Image Analysis
Two-dimensional gel electrophoresis (2-DE) was carried
out with Amersham Biosystems IPGphor IEF and Bio-Rad
protein αXI cell vertical electrophoresis bath system (Bio-
Rad CO.) according to the protocol described [3]. All
samples were run at least in duplicate to guarantee
reproducibility. Two good quality gels for each case were
included into the subsequent image analysis. Coomassie
brilliant blue staining was performed as described [4].
Image Analysis and MS Peptide Sequencing
The image of two-dimensional gels were digitalized with an
ImageScanner and were conducted with ImageMaster 2D
v2002.1 software (Amersham Pharmacia). The normalized
value for each protein spot volume was used for compar-
ison. Only those spots that have statistical significance in
differential expression were selected for further investi-
gation. Protein spots were cut out of gels in small pieces
and subjected to in-gel tryptic digestion overnight. Peptide
mass spectra were recorded, and parameters for spectra
acquisition were used as stated [3]. A Voyage-DE STR
matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometer (Applied Biosystems,
Foster City, CA, USA) was employed to obtain the peptide
mass spectra with the following settings: reflector mode
with 175 ns delay extraction time, 60–65% grid voltage,
and 20 kV accelerating voltage. Laser shots of 250 per
spectrum were used to acquire the spectra with a mass
range of 500–4,000 Da. Mass calibration was performed
using autolytic fragment peaks of trypsin including
906.5049, 1,153.5741, and 2,163.0570 Da. Proteins were
identified by peptide fingerprinting using MS-Fit to search
the NCBInr protein database (http://prospector.ucsf.edu). In
database protein matching using MS-Fit (http://prospector.
ucsf.edu/), 25 ppm or better mass accuracy and Mowse
scores more than 200 were obtained in most of the
analyses. Duplicate or triplicate runs were performed to
ensure an accurate analysis. Western blotting was per-
formed to confirm the specificity of the identified proteins,
if necessary.
Western Blotting
Protein samples were run on gel using the identical
conditions as stated for 2-DE in “2-DE, Coomassie
Staining, and Image Analysis.” The separated proteins in
the corresponding areas from the gels were transferred onto
polyvinylidene difluoride membranes and incubated over-
night at 4°C with a blocking buffer containing Tris-buffered
saline, 0.1% Tween 20 (TBST), and 5% nonfat dry milk.
Membranes were washed with TBST and incubated with
monoclonal or polyclonal antibodies at a 1:500 or 1:1,000
dilution for 1 h at room temperature or overnight at 4°C.
After washing again with TBST, the membranes were
blotted with a secondary antibody conjugated with horse-
radish peroxidase at a 1:10,000 dilution for 1 h and then
detected by enhanced chemiluminescence (Santa Cruz
Biotechnology, Inc., USA) for 1 min.
Results
Protein Separation
Figure 1 is a typical two-dimensional gel image for the
tumor tissue of LSCC. More than 800 protein spots were
separated in a 13×16-cm gel, with magnetic resonance (Mr)
Clin Proteom (2007) 3:42–47 43
ranging from 6.5 to 200 kDa and pI from 3 to 10.
Highlighted in squares are the five areas where significant
and consistent volume differences of protein spots were
found when comparisons were made between normal and
tumor tissue samples. Except for three proteins (fatty acid-
binding protein [FABP], calgranulin A, and calgranulin B)
that were almost below the level of detection in tumor
tissue, all other identified proteins were substantially
upregulated in LSCC samples. Statistic data for these
proteins are summarized in Table 1 with fold differences
between tumor and normal mucosae samples (for a total of
eight pairs indicated). Roughly ten proteins are upregulated,
and three proteins are suppressed significantly in tumor
tissues.
Protein Identification
Each protein spot was excised and subjected to in-gel
tryptic digestion, MALDI-TOF mass measurement, and
database matching. Isoforms that gave an identical primary
structure in the protein matching were classified as one
protein. Table 1 is a summary of the proteins identified.
Figures 1 and 2 show the alterations in the expression levels
of the identified proteins between tumor and normal
mucosae. Proteins that consistently displayed an apparent
increase in their expression level in tumor samples include
cofilin-1, GRP94, HSP 90, GSTP1-1, superoxide dismutase
[Mn], cyclophilin A, and calmodulin (CaM)-like protein.
Proteins considerably suppressed in tumor samples includ-
ed E-FABP, calgranulin A, and calgranulin B. The majority
of these proteins have Mrs that match their experimental
values determined from gels.
Protein ID and Expression Confirmation by Western
Blotting
Western blotting was performed to verify two selected
proteins, cyclophilin A and calgranulin A, that may play
functional roles in tumorigenesis. Figures 3 and 4 shows the
Western blotting results for the two proteins. Figure 4
displays the representative gels of Western blotting, con-
firming the decreased expressions of calgranulin A in tumor
tissues. Western blotting results shown in Fig. 3 exhibit the
increased expression levels of cyclophilin A.
Discussion
Although numerous studies in the genomic field have
revealed a magnitude of changes occurring in the multi-
Fig. 1 2-DE image of LSCC
Table 1 Statistic data for these proteins with fold differences between tumor and normal mucosae samples
Spot Protein name Area pI Peptides matched Molecular mass Mowse score Change (fold)
1 Cofilin-1 I 8.3 5 18,401 3,547 −2.7
2 Cyclophilin A I 7.8 8 17,881 7.11e+6 −6.6
3 CaM-like protein II 4.3 10 16,760 77,670 −1.5
4 GRP94 III 4.8 13 92,470 2.17e+9 −3.9
5 HSP90 III 5.0 17 83,134 4.94e+10 −4.2
6 Nuclear body protein SP140 III 5.3 8 99,871 35,504 −3.3
7 Glutathione S-transferase P IV 5.4 11 23,225 5.26e+8 −1.4
8 Superoxide dismutase [Mn] IV 6.9 7 23,673 1,042 −1.8
9 Proteasome activator complex subunit2 IV 5.4 6 27,231 192,232 −3.6
10 Apolipoprotein A−I precursor IV 5.7 18 30,277 7.85e+10 −4.0
11 Fatty acid-binding protein, epidermal V 6.8 9 15,033 1.70e+6 +2.9
12 Calgranulin B V 5.7 4 13,242 6,625 +3.4
13 Calgranulin A V 6.5 6 10,835 29,279 +5.2
1–10 the protein spots upregulate, 11–l3 the protein spots downregulate
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stage pathogenesis of LSCC, including mutations of a
variety of tumor suppressor genes and oncogenes, changes
in transcription, proliferation-associated factors, and metas-
tasis-related factors, these changes may not necessarily
warrant subsequent corresponding alternations at the pro-
tein levels or functions. Proteomics, which aims at
characterizing the entire protein complement expressed in
cells or tissues, provides complementary information and
direct evidence to unravel tumor-specific molecular events
during multistage carcinogenesis. In the present study, we
used 2-DE-based proteomics to examine the protein profiles
of cancer tissues and the adjacent nontumor tissues and to
identify proteins related to laryngeal malignancy. A total of
13 proteins were uncovered with differential expressions in
laryngeal carcinogenesis, among which ten were upregu-
lated and three were downregulated. In summary, we used
two-dimensional gel-based proteomics to compare the
protein profiles between LSCC tumor and matched
surrounding tissues and to identify differently expressed
proteins in the laryngeal cancer. A number of tumor-
associated proteins proved that proteomic analysis can
provide rich information to help understand the pathology
of a disease in an integrated way. This type of information
should lead to more rationally designed diagnostic and
treatment methods, which will hopefully translate into
improved patient outcome.
CypA is a multifunctional cytokine involved in many
biological processes, including protein folding, immuno-
suppression, cellular signaling, and apoptosis. Overexpres-
sion of CypA also was observed in non-small-cell lung
cancer [5] and in human oral cancer cell lines [6] and
pancreatic cancer. CypA could stimulate Panc-1 cell
proliferation in a dose-dependent manner through its
cellular receptor CD147 by activating the ERK1/2 and
p38 pathways. Overexpression of CypA in laryngeal
carcinoma indicated that it might play an important role in
carcinogenesis, invasive action, and metastasis of LSCC.
Calgranulin A and calgranulin B also are named
S100A8/MRP8 and S100A9/MRP14, respectively. S100
proteins, a multigenic family of calcium-binding proteins,
have been linked to human pathologies in recent years.
Deregulated expression of S100 proteins, including
S100A8 and S100A9, was reported in association with
neoplastic disorders. Aberrant S100A8 or S100A9 expres-
sion has been reported in a variety of epithelial tumors,
including gastric, ovarian, colon, and breast cancers [7, 10]
and prostate carcinomas [8, 11], as well as pulmonary and
pancreatic adenocarcinomas [12, 13]. Interestingly, S100A8
is constitutively expressed in terminally differentiated
squamous epithelium but lost in squamous cell carcinomas,
such as esophageal squamous cell carcinoma, correlating
with poor differentiation [14, 15]. However, the detection
of S100A8/9 can be used to discriminate pancreatic cancerFig. 3 Expression of CypA in laryngeal carcinoma and normal tissue
Fig. 4 Expression of MRP8 in laryngeal carcinoma and normal tissue
Fig. 2 Protein alterations in areas I–V
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from pancreatitis [13] and ovarian cancer from benign
ovarian cysts [9] lending support to an overexpression in
tumors. Nevertheless, our current study revealed that
S100A8 and S100A9 were downregulations in the tissues
of laryngocarcinoma. The pathologic significance of their
discordant expression in different tumors will be our
research topic in future.
Also known as ER modulin, GRP94 is a member of
HSP90 family. HSP90 is usually considered as the cell
survival factor, when the cell is stimulated by environment,
will enhance expression of the heat shock protein. It can
prevent the cell from attack of the endogenous stress quickly
and transiently, reinforce the ability of recovery, and enhance
the tolerance to the stress [16]. GRP94 plays an important
role in the tumorigenesis and the survival of the tumor cells.
As an important part of oncogene pathway, many signal
transducers depend on HSP90 to play their role. In laryngeal
carcinoma, GRP94 and HSP90 upexpressions indicate that
the Ego defense mechanism of the cell is activated to cope
with the malignant transformation of the cell.
CaM is one of the most important intracellular calcium-
binding protein, and it is the chief intracellular Ca2+ signal
transmitter. As a multifunctional enzyme regulator, CaM is
concerned with multitude vital phenomena, it influences
cell growth and cell proliferation, and also, it may play a
role in regulating the oncogene protein [17]. Many
researches have found that CaM has a higher level in
tumor cells such as breast cancer, leukemia, hepatoma, and
lung cancer. It was confirmed that CaM has inhibitory
action on proliferation and metastasis of the tumor in years
1970–1980.
COF1 probably participates in cell movement through
reversible phosphorylation regulation of actin and plays an
important role in tumor metastasis [18]. Some researchers
have pointed out that adenosine-triphosphate-supported
actin filament treading pedal is the impetus basis of actin
persistent movement and this effect is regulated by COF,
microfilament binding protein profiling, and capping
protein. The depolymerization and polymerization of the
actin promote the movement and metastasis of tumor cells.
Manganese superoxide dismutase (MnSOD) and gluta-
thione S transferring enzyme P are intracellular frequent
antioxidase. Increase of MnSOD indicates the activation of
the familiar antioxidize defense mechanism. Many
researches showed that MnSOD can prevent the cell from
damage and can inhibit tumor growth, probably through
changing the oxidation-reduction reaction circumstances of
chondriosome and metabolic capability of the cell [19].
GSTP1-1 belongs to the cytolist enzyme family, participat-
ing in the process of detoxication [20]. In many kinds of
tumors such as didymus tumor, ovaries tumor and colon
tumor, overexpression of GSTP1-1 is associated with
tumorigenesis and tumor development.
E-FABP, a familiar FABP, is associated with the
psoriasis, which is in high-level expression in epidermis
of psoriasis [21]. Its high-level expression was also found
in bladder, pancreatic, and head and neck squamous
carcinomas. The overexpression of E-FABP was also
correlated to tumor metastasis. In contrast, E-FABP was
found in low-level expression in tissues of laryngocarci-
noma compared with the normal tissues in this study;
further analysis to understand this inconsistence is in
progress.
In conclusion, a number of proteins were found to be
significantly altered in well-differentiated laryngeal carci-
noma tissues by comparing to the adjacent non-tumor
tissues through proteomic analysis, suggesting that multiple
molecular pathways were involved in the tumorigenesis.
Some of the identified proteins were validated by Western
blotting to confirm their altered expressions in tissues.
These tumor-associated proteins can be further charac-
terized and evaluated as potential biomarkers for diagnosis
of laryngeal carcinoma or as target molecules for pathoge-
netic study.
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